Siemens Healthcare Diagnostics Products has confirmed that the mentioned Enzygnost Anti-VZV/IgG lots can show a higher variation in homogeneity. This can lead to invalid runs by not meeting the run validation criterion for the reference p/n at the start and end of a series.